Literature DB >> 30655289

DNA polymerase θ (POLQ) is important for repair of DNA double-strand breaks caused by fork collapse.

Zi Wang1,2, Yadong Song1,3, Shibo Li1, Sunil Kurian4, Rong Xiang3, Takuya Chiba2, Xiaohua Wu5.   

Abstract

DNA polymerase θ (POLQ) plays an important role in alternative nonhomologous end joining or microhomology-mediated end joining (alt-NHEJ/MMEJ). Here, we show that POLQ is not only required for MMEJ to repair DNA double-strand breaks (DSBs) generated by endonucleases such as I-SceI or Cas9, but is also needed for repair of DSBs derived from DNA nicks generated by Cas9 nickase. Consistently, we found that POLQ deficiency leads to sensitivity to topoisomerase inhibitors that cause DNA single-strand break (SSB) accumulation at replication forks and to ATR inhibitors that induce replication fork collapse. These studies support the function of POLQ in coping with replication stress and repairing DSBs upon fork collapse. POLQ overexpression is present in many cancer types and is associated with poor prognosis, including breast cancer regardless of BRCA1 status. We provide proof-of-concept evidence to support a novel cancer treatment strategy that combines POLQ inhibition with administration of topoisomerase or ATR inhibitors, which induces replication stress and fork collapse. Given the prevalence of POLQ overexpression in tumors, such strategy may have a significant impact on developing targeted cancer treatment.
© 2019 Wang et al.

Entities:  

Keywords:  ATR kinase; DNA double-strand break repair; DNA repair; DNA replication stress; POLQ; breast cancer; cancer; genome integrity; genomic instability; inhibitor; microhomology-mediated end joining

Mesh:

Substances:

Year:  2019        PMID: 30655289      PMCID: PMC6422074          DOI: 10.1074/jbc.RA118.005188

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Lack of DNA polymerase theta (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiation.

Authors:  Julie P Goff; Donna S Shields; Mineaki Seki; Serah Choi; Michael W Epperly; Tracy Dixon; Hong Wang; Christopher J Bakkenist; Stephen D Dertinger; Dorothea K Torous; John Wittschieben; Richard D Wood; Joel S Greenberger
Journal:  Radiat Res       Date:  2009-08       Impact factor: 2.841

Review 2.  Microhomology-mediated end joining: Good, bad and ugly.

Authors:  Ja-Hwan Seol; Eun Yong Shim; Sang Eun Lee
Journal:  Mutat Res       Date:  2017-07-16       Impact factor: 2.433

3.  Phenotype-based identification of mouse chromosome instability mutants.

Authors:  Naoko Shima; Suzanne A Hartford; Ted Duffy; Lawriston A Wilson; Kerry J Schimenti; John C Schimenti
Journal:  Genetics       Date:  2003-03       Impact factor: 4.562

4.  Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells.

Authors:  Lan N Truong; Yongjiang Li; Linda Z Shi; Patty Yi-Hwa Hwang; Jing He; Hailong Wang; Niema Razavian; Michael W Berns; Xiaohua Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

5.  Overexpression of POLQ confers a poor prognosis in early breast cancer patients.

Authors:  Geoff S Higgins; Adrian L Harris; Remko Prevo; Thomas Helleday; W Gillies McKenna; Francesca M Buffa
Journal:  Oncotarget       Date:  2010-07

6.  The mouse genomic instability mutation chaos1 is an allele of Polq that exhibits genetic interaction with Atm.

Authors:  Naoko Shima; Robert J Munroe; John C Schimenti
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells.

Authors:  Roberto Chiarle; Yu Zhang; Richard L Frock; Susanna M Lewis; Benoit Molinie; Yu-Jui Ho; Darienne R Myers; Vivian W Choi; Mara Compagno; Daniel J Malkin; Donna Neuberg; Stefano Monti; Cosmas C Giallourakis; Monica Gostissa; Frederick W Alt
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

8.  Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.

Authors:  Rebeka Sultana; Tarek Abdel-Fatah; Christina Perry; Paul Moseley; Nada Albarakti; Vivek Mohan; Claire Seedhouse; Stephen Chan; Srinivasan Madhusudan
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

9.  Efficacy of ATR inhibitors as single agents in Ewing sarcoma.

Authors:  Maria Nieto-Soler; Isabel Morgado-Palacin; Vanesa Lafarga; Emilio Lecona; Matilde Murga; Elsa Callen; Daniel Azorin; Javier Alonso; Andres J Lopez-Contreras; Andre Nussenzweig; Oscar Fernandez-Capetillo
Journal:  Oncotarget       Date:  2016-09-13

10.  Complex landscapes of somatic rearrangement in human breast cancer genomes.

Authors:  Philip J Stephens; David J McBride; Meng-Lay Lin; Ignacio Varela; Erin D Pleasance; Jared T Simpson; Lucy A Stebbings; Catherine Leroy; Sarah Edkins; Laura J Mudie; Chris D Greenman; Mingming Jia; Calli Latimer; Jon W Teague; King Wai Lau; John Burton; Michael A Quail; Harold Swerdlow; Carol Churcher; Rachael Natrajan; Anieta M Sieuwerts; John W M Martens; Daniel P Silver; Anita Langerød; Hege E G Russnes; John A Foekens; Jorge S Reis-Filho; Laura van 't Veer; Andrea L Richardson; Anne-Lise Børresen-Dale; Peter J Campbell; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-24       Impact factor: 49.962

View more
  25 in total

1.  Epigenetic Regulation of DNA Repair Pathway Choice by MacroH2A1 Splice Variants Ensures Genome Stability.

Authors:  Robin Sebastian; Eri K Hosogane; Eric G Sun; Andy D Tran; William C Reinhold; Sandra Burkett; David M Sturgill; Prabhakar R Gudla; Yves Pommier; Mirit I Aladjem; Philipp Oberdoerffer
Journal:  Mol Cell       Date:  2020-07-09       Impact factor: 17.970

Review 2.  Synthetic Lethality through the Lens of Medicinal Chemistry.

Authors:  Samuel H Myers; Jose Antonio Ortega; Andrea Cavalli
Journal:  J Med Chem       Date:  2020-11-02       Impact factor: 7.446

Review 3.  DNA polymerase theta (Polθ) - an error-prone polymerase necessary for genome stability.

Authors:  Alessandra Brambati; Raymond Mario Barry; Agnel Sfeir
Journal:  Curr Opin Genet Dev       Date:  2020-04-14       Impact factor: 5.578

4.  POLQ suppresses genome instability and alterations in DNA repeat tract lengths.

Authors:  Kate Liddiard; Alys N Aston-Evans; Kez Cleal; Eric A Hendrickson; Duncan M Baird
Journal:  NAR Cancer       Date:  2022-06-29

Review 5.  Synthetic Lethality Targeting Polθ.

Authors:  Małgorzata Drzewiecka; Gabriela Barszczewska-Pietraszek; Piotr Czarny; Tomasz Skorski; Tomasz Śliwiński
Journal:  Genes (Basel)       Date:  2022-06-20       Impact factor: 4.141

6.  POLQ suppresses interhomolog recombination and loss of heterozygosity at targeted DNA breaks.

Authors:  Luther Davis; Kevin J Khoo; Yinbo Zhang; Nancy Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-01       Impact factor: 11.205

Review 7.  Exploiting the Microhomology-Mediated End-Joining Pathway in Cancer Therapy.

Authors:  Jeffrey Patterson-Fortin; Alan D D'Andrea
Journal:  Cancer Res       Date:  2020-07-10       Impact factor: 12.701

Review 8.  Mechanism, cellular functions and cancer roles of polymerase-theta-mediated DNA end joining.

Authors:  Dale A Ramsden; Juan Carvajal-Garcia; Gaorav P Gupta
Journal:  Nat Rev Mol Cell Biol       Date:  2021-09-14       Impact factor: 94.444

9.  Preservation of lagging strand integrity at sites of stalled replication by Pol α-primase and 9-1-1 complex.

Authors:  Robin van Schendel; Ron Romeijn; Helena Buijs; Marcel Tijsterman
Journal:  Sci Adv       Date:  2021-05-19       Impact factor: 14.136

Review 10.  Mutational signatures: emerging concepts, caveats and clinical applications.

Authors:  Gene Koh; Andrea Degasperi; Xueqing Zou; Sophie Momen; Serena Nik-Zainal
Journal:  Nat Rev Cancer       Date:  2021-07-27       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.